XML 21 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities      
Net income $ 128,579 $ 224,270 $ 160,694
Adjustments to reconcile net income to net cash from operating activities:      
Depreciation and amortization 367,162 336,274 300,946
Loss on early retirement of debt 176 11,995 0
Gain on sale of operating properties, including land (382) (49,901) 0
Distributions of income from joint ventures 8,389 14,843 7,736
Equity in income of joint ventures [1] (8,052) [2] (14,783) (7,836) [2]
Share-based compensation 13,942 15,235 16,749
Net change in operating accounts and other 9,505 38,094 9,553
Receipts for settlement of forward interest rate swaps 0 (20,430) 15,905
Net cash from operating activities 519,319 555,597 503,747
Cash flows from investing activities      
Development and capital improvements, including land (427,247) (407,558) (359,230)
Acquisition of operating properties 0 (436,305) (290,005)
Proceeds from sales of operating properties, including land 753 67,572 11,296
Increase in non-real estate assets (7,498) (17,197) (14,503)
Decrease in notes receivable 1,449 1,394 9,475
Other 2,941 (351) 2,046
Net cash from investing activities (429,602) (792,445) (640,921)
Cash flows from financing activities      
Borrowings on unsecured credit facility and other short-term borrowings 358,000 1,217,000 342,000
Repayments on unsecured credit facility and other short-term borrowings (402,000) (1,173,000) (342,000)
Repayment of notes payable (100,000) (746,730) (381,438)
Proceeds from notes payable 782,823 889,979 495,545
Distributions to common shareholders and non-controlling interests (333,360) (317,253) (298,005)
Payment of deferred financing costs (1,308) (5,965) (914)
Proceeds from issuance of common shares 0 353,213 0
Repurchase of common shares and redemption of units 0 0 (14,668)
Other 3,162 3,500 2,452
Net cash from financing activities 307,317 220,744 (197,028)
Net increase (decrease) in cash, cash equivalents, and restricted cash 397,034 (16,104) (334,202)
Cash, cash equivalents, and restricted cash, beginning of year 27,499 43,603 377,805
Cash, cash equivalents, and restricted cash, end of year 424,533 27,499 43,603
Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheets [Abstract]      
Total cash, cash equivalents, and restricted cash 27,499 27,499 377,805
Supplemental information      
Cash paid for interest, net of interest capitalized 90,297 71,248 81,299
Cash paid for income taxes 2,292 1,291 1,951
Supplemental schedule of noncash investing and financing activities      
Distributions declared but not paid 84,147 80,973 74,982
Value of shares issued under benefit plans, net of cancellations 19,560 18,249 17,253
Accrual associated with construction and capital expenditures 29,611 27,162 35,588
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability $ 676 $ 15,017 $ 0
[1] Equity in income excludes our ownership interest of fee income from various services provided by us to the Funds.
[2] Equity in income for the year ended December 31, 2020 includes our ownership interest of the Resident Relief Funds payments of approximately $0.4 million. Equity in income for the year ended December 31, 2019 includes our ownership interest of the gain on sale of the operating property of approximately $6.2 million.